Björn Redfors, MD, PhD1; Akiko Maehara, MD1,2; Bernhard Witzenbichler, MD3; Giora Weisz, MD1,2,4; Thomas D. Stuckey, MD5; Timothy D. Henry, MD6,7; Thomas McAndrew, PhD1; Roxana Mehran, MD1,8; Ajay J. Kirtane, MD, SM1,2; Gregg W. Stone, MD1,2; Philippe Généreux, MD1,9,10
Björn Redfors, MD, PhD1; Akiko Maeha...
We report the adverse event rates after rotational atherectomy (RA) with contemporary drug-eluting stent implantation and compare RA to cutting balloon angioplasty and balloon-only angioplasty in the all-comers ADAPT-DES trial.
We report the adverse event rates after rotational atherectomy (RA) with contemporary drug-eluting stent implantation and compare RA to cutting balloon angioplasty and balloon-only angioplasty in the all-comers ADAPT-DES trial.